The safety assessment of the Authority on the primary product Scansmoke PB1110, adopted on 26 March 2009 [EFSA Journal 2009; ON-1056, 1-23.], concludes that the data provided by the applicant is sufficient to eliminate the concerns over its genotoxicity. However the uses and use levels as originally proposed by the applicant would provide an insufficient margin of safety. The uses and the use levels have been revised to take into account this opinion. The primary product Scansmoke PB1110 should therefore be authorised subject to specific conditions of use.
Recital 5, Commission Implementing Regulation (EU) No 1321/2013 of 10 December 2013 establishing th…
In forcesince 10 Dec 2013